Pros, Eva <br/><br/>
Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.  [electronic resource] 

 -  Human mutation  Mar 2009 
 - 454-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-1004 
<br/><br/><label>Standard No.: </label>10.1002/humu.20933  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alternative Splicing<br/>Base Sequence<br/>Blotting, Western<br/>Cell Line, Transformed<br/>Cells, Cultured<br/>Fibroblasts--cytology<br/>Gene Expression--drug effects<br/>Humans<br/>Introns--genetics<br/>Morpholines--chemistry<br/>Mutation<br/>Neurofibromatosis 1--genetics<br/>Neurofibromin 1--genetics<br/>Oligodeoxyribonucleotides, Antisense--chemistry<br/>RNA Splice Sites--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>ras Proteins--metabolism